Medical disclaimer: This website is for research and education only. Nothing here is medical advice, diagnosis, treatment, or a recommendation to use any peptide, supplement, or protocol. Always consult a qualified healthcare provider before making health decisions. Read the full disclaimer.

Citation search

Every source behind the compound library in one place. Search by journal, study title, year, or any wording in the abstract and methodology notes — then jump to the compounds that rely on it.

Showing 25 of 25 sources across 18 compounds (25 indexed).

  • Urolithin A improves muscle strength and mitochondrial health

    Cited by Urolithin A

    Cell Reports Medicine · 2022

    In vitroCells / synthesisLimited grade

    Urolithin A improves muscle strength and mitochondrial health examines Urolithin A in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • MOTS-c is an exercise-induced mitochondrial-encoded regulator

    Cited by MOTS-c

    Nature Communications · 2021

    In vitroCells / synthesisLimited grade

    MOTS-c is an exercise-induced mitochondrial-encoded regulator examines MOTS-c in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Cerebrolysin in traumatic brain injury

    Cited by Cerebrolysin

    Journal of Neurotrauma · 2020

    In vitroCells / synthesisLimited grade

    Cerebrolysin in traumatic brain injury examines Cerebrolysin in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Chronic nicotinamide riboside supplementation in healthy middle-aged adults

    Cited by NAD+ precursors

    Nature Communications · 2018

    Human trialHumanModerate grade

    Chronic nicotinamide riboside supplementation in healthy middle-aged adults reports human data on NAD+ precursors collected without randomisation or a control arm — typically an open-label or single-group observation.

    View source
  • Elamipretide in primary mitochondrial myopathy

    Cited by SS-31

    Neurology · 2018

    In vitroCells / synthesisLimited grade

    Elamipretide in primary mitochondrial myopathy examines SS-31 in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Stable gastric pentadecapeptide BPC 157 and the gut-brain axis

    Cited by BPC-157

    Current Neuropharmacology · 2016

    In vitroCells / synthesisLimited grade

    Stable gastric pentadecapeptide BPC 157 and the gut-brain axis examines BPC-157 in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Selank effects on GABA-ergic gene expression

    Cited by Selank

    Journal of Molecular Neuroscience · 2016

    In vitroCells / synthesisLimited grade

    Selank effects on GABA-ergic gene expression examines Selank in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • GHK-Cu in human tissue remodelling and anti-ageing

    Cited by GHK-Cu

    BioMed Research International · 2015

    Human trialHumanModerate grade

    GHK-Cu in human tissue remodelling and anti-ageing reports human data on GHK-Cu collected without randomisation or a control arm — typically an open-label or single-group observation.

    View source
  • The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis

    Cited by MOTS-c

    Cell Metabolism · 2015

    In vitroCells / synthesisLimited grade

    The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis examines MOTS-c in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Neurotrophic peptide P21 and hippocampal neurogenesis

    Cited by P21

    Journal of Alzheimer's Disease · 2014

    In vitroCells / synthesisLimited grade

    Neurotrophic peptide P21 and hippocampal neurogenesis examines P21 in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Cerebrolysin for vascular dementia (Cochrane review)

    Cited by Cerebrolysin

    Cochrane Database of Systematic Reviews · 2013

    Review / meta-analysisCells / synthesisModerate grade

    Cerebrolysin for vascular dementia (Cochrane review) synthesises previously published work on Cerebrolysin. Its conclusions inherit the strengths and limits of the studies it reviews.

    View source
  • Dihexa: angiotensin IV analogue and synaptogenesis

    Cited by Dihexa

    Journal of Pharmacology and Experimental Therapeutics · 2013

    In vitroCells / synthesisLimited grade

    Dihexa: angiotensin IV analogue and synaptogenesis examines Dihexa in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Cardiolipin-targeted peptides and mitochondrial protection

    Cited by SS-31

    Journal of the American Society of Nephrology · 2013

    In vitroCells / synthesisLimited grade

    Cardiolipin-targeted peptides and mitochondrial protection examines SS-31 in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Thymosin alpha-1 in severe sepsis: a randomised controlled trial

    Cited by Thymosin Alpha-1

    Critical Care · 2013

    Human RCTHumanStrong grade

    Thymosin alpha-1 in severe sepsis: a randomised controlled trial reports a randomised, controlled human trial relevant to Thymosin Alpha-1. Participants were allocated to Thymosin Alpha-1 or a control arm and outcomes compared between groups.

    View source
  • Thymosin beta-4 and tissue repair

    Cited by TB-500

    Annals of the New York Academy of Sciences · 2012

    In vitroCells / synthesisLimited grade

    Thymosin beta-4 and tissue repair examines TB-500 in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Semax in acute ischaemic stroke

    Cited by Semax

    Zhurnal Nevrologii i Psikhiatrii · 2011

    Human trialHumanModerate grade

    Semax in acute ischaemic stroke reports human data on Semax collected without randomisation or a control arm — typically an open-label or single-group observation.

    View source
  • KPV and colonic inflammation

    Cited by KPV

    Journal of Clinical Investigation · 2008

    Human trialHumanModerate grade

    KPV and colonic inflammation reports human data on KPV collected without randomisation or a control arm — typically an open-label or single-group observation.

    View source
  • Noopept effects on BDNF and NGF expression in rat hippocampus

    Cited by Noopept

    Bulletin of Experimental Biology and Medicine · 2008

    Animal studyAnimalLimited grade

    Noopept effects on BDNF and NGF expression in rat hippocampus reports an animal model investigating Noopept. Findings describe effects in the model organism, not confirmed outcomes in people.

    View source
  • Selank versus medazepam in generalised anxiety disorder

    Cited by Selank

    Zhurnal Nevrologii i Psikhiatrii · 2008

    In vitroCells / synthesisLimited grade

    Selank versus medazepam in generalised anxiety disorder examines Selank in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Semax and BDNF expression in rat hippocampus

    Cited by Semax

    Neuroscience Letters · 2006

    Animal studyAnimalLimited grade

    Semax and BDNF expression in rat hippocampus reports an animal model investigating Semax. Findings describe effects in the model organism, not confirmed outcomes in people.

    View source
  • BPC 157 and tendon healing

    Cited by BPC-157

    Journal of Orthopaedic Research · 2003

    In vitroCells / synthesisLimited grade

    BPC 157 and tendon healing examines BPC-157 in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • Epithalamin and melatonin rhythm in elderly subjects

    Cited by Epitalon

    Neuroendocrinology Letters · 2003

    Human trialHumanModerate grade

    Epithalamin and melatonin rhythm in elderly subjects reports human data on Epitalon collected without randomisation or a control arm — typically an open-label or single-group observation.

    View source
  • Humanin: a rescue factor against Alzheimer's disease-related neurotoxicity

    Cited by Humanin

    Proceedings of the National Academy of Sciences · 2001

    Human trialHumanModerate grade

    Humanin: a rescue factor against Alzheimer's disease-related neurotoxicity reports human data on Humanin collected without randomisation or a control arm — typically an open-label or single-group observation.

    View source
  • DSIP in chronic insomnia

    Cited by DSIP

    European Neurology · 1986

    In vitroCells / synthesisLimited grade

    DSIP in chronic insomnia examines DSIP in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source
  • DSIP in opiate and alcohol withdrawal

    Cited by DSIP

    Pharmacology Biochemistry and Behavior · 1984

    In vitroCells / synthesisLimited grade

    DSIP in opiate and alcohol withdrawal examines DSIP in cells or tissue outside a living organism, characterising mechanism rather than clinical outcome.

    View source